Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do statins decrease cardiovascular disease at the expense of increasing cancer?

Mark R Goldstein, Luca Mascitelli

    International Journal of Cardiology
    |January 1, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PSA Screening and Prostate Cancer Mortality.

    JAMA·2024
    Same author

    Inflammation, infection, and cardiovascular risk.

    Lancet (London, England)·2024
    Same author

    Bempedoic Acid for Primary Prevention of Cardiovascular Events.

    JAMA·2023
    Same author

    Comment regarding: "COVID-19 vaccination may enhance hippocampal neurogenesis in adults".

    Brain, behavior, and immunity·2022
    Same author

    Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"

    Neuroscience and biobehavioral reviews·2022
    Same author

    The Increasing Incidence of Early-Onset Colorectal Cancer.

    The New England journal of medicine·2022
    Same journal

    Fully quantitative CMR rest perfusion reveals myocardial perfusion abnormality in Kawasaki disease: Association with left ventricular Remodeling.

    International journal of cardiology·2026
    Same journal

    Predicted adherence and ischaemic stroke risk in atrial fibrillation patients initiating oral anticoagulation: A cohort study of the medication adherence score.

    International journal of cardiology·2026
    Same journal

    Severe tricuspid regurgitation is a congestion-driven cardiorenal disease: A longitudinal study defining a right heart failure phenotype.

    International journal of cardiology·2026
    Same journal

    Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

    International journal of cardiology·2026
    Same journal

    Effectiveness of a new diagnostic algorithm for the diagnosis of unexplained syncope in patients with hypertrophic cardiomyopathy.

    International journal of cardiology·2026
    Same journal

    The predictive role of the FIB-4 index in identifying arrhythmic risk among patients with nonischemic dilated cardiomyopathy.

    International journal of cardiology·2026
    See all related articles

    Recent findings suggest a link between lower cholesterol and increased cancer risk, challenging aggressive cholesterol-lowering trends with statins. Further research is needed to understand this complex relationship, especially in vulnerable populations.

    Area of Science:

    • Cardiovascular Medicine
    • Oncology
    • Pharmacology

    Background:

    • Emerging evidence indicates an inverse correlation between low-density lipoprotein (LDL) cholesterol levels and cancer incidence.
    • Aggressive cholesterol-lowering therapies, particularly statin use, are increasingly prevalent, necessitating a re-evaluation of their broader health implications.
    • The trend towards intensive LDL reduction requires careful consideration of potential unintended consequences.

    Discussion:

    • Data suggests that cholesterol lowering may increase cancer risk, potentially offsetting cardiovascular benefits in specific groups like the elderly.
    • Individuals undergoing cancer immunotherapy may also be at increased risk of cancer when cholesterol levels are significantly lowered.
    • A potential dose-dependent relationship between statin therapy and cancer incidence warrants further investigation.

    Related Experiment Videos

    Key Insights:

    • The complex interplay between cholesterol levels and cancer incidence requires nuanced understanding.
    • Specific patient populations, including the elderly and those on immunotherapy, may be more susceptible to adverse effects of cholesterol lowering.
    • The potential for statin dose to influence cancer risk highlights the need for personalized treatment strategies.

    Outlook:

    • Future clinical trials investigating statins must incorporate rigorous tracking of cancer incidence over extended periods.
    • Further research is essential to elucidate the mechanisms underlying the cholesterol-cancer relationship.
    • Clinical guidelines for cholesterol management may need refinement to account for cancer risk in certain populations.